Simvastatin could downregulate NLRP3-related pyroptosis and attenuate lung injury in hyperoxia-induced bronchopulmonary dysplasia via a KLF2-mediated mechanism (Wang et al., 2022). This evidence concerns the gene KLF2 and bronchopulmonary dysplasia.